St. Jude Survivorship Study ASCO 17
107 views · Published 2 June 2017 · 1:20 · Indexed 6 November 2026
Channel: MultiVu · 2017 · News & Politics
Changes in the treatment of pediatric cancer over recent decades have translated to a reduced risk of serious, long-term late health effects of cancer therapy. This is according to the latest analysis from the Childhood Cancer Survivor Study (CCSS), a National Cancer Institute-funded resource for late-effects research, led by investigators at St. Jude Children’s Research Hospital. “This is the first comprehensive study to demonstrate how changes in treatments over time have impacted the occurrence of late effects experienced by childhood cancer survivors,” said Todd Gibson, Ph.D., assistant member of the Department of Epidemiology and Cancer Control at St. Jude. “We found the 15-year cumulative incidence of people reporting at least one severe health condition decreased from 12.7 percent among childhood cancer survivors diagnosed in the 1970s to 10.1 percent for those diagnosed in the 1980s to 8.8 percent in the 1990s–a statistically significant decline.” To view the multimedia release go to: https://www.multivu.com/players/English/7924756-st-jude-childhood-cancer-survivorship-asco-2017/
More from this channel
-
2:24
Nespresso by KitchenAid
-
0:53
Best Skincare & Makeup Reviews
-
5:01
AARP Magazine With Sheryl Crow and Melissa Etheridge
-
1:57
Concentrix Flagship Delivery Center
-
1:09
Casino Gaming’s Economic Impact
-
2:00
Anchor it and Protect a Child
-
2:42
The PowerHaul Locomotive Platform
-
0:31
New PSA aims to bridge opportunity divide